[ Price : $8.95]
Based on FDA feedback, NeuroSense Therapeutics says it will begin a Phase 3 study of PrimeC (ciprofloxacin and celecoxib) for trea...[ Price : $8.95]
Johnson & Johnson reports data from its Phase 3 CARTITUDE-4 study that show Carvykti significantly increased minimal residual dise...[ Price : $8.95]
Two men are convicted of securities fraud in a case involving misrepresented submissions to FDA for a drug purportedly intended to...[ Price : $8.95]
FDA warns Chinas Guangzhou Four Es Scientific Co. about CGMP violations in its production of finished drugs.[ Price : $8.95]
Getinge/Maquet issues a Class 1 recall (device correction) to inform users about important safety information for its VasoView Hem...[ Price : $8.95]
Four Ropes & Gray attorneys analyze a 9th Circuit Appeals Court decision backing FDA regulation of stem cell products and raise th...[ Price : $8.95]
FDA denies a Metacel petition asking the agency to require flavoring tests for generic forms of the companys Ozobax.[ Price : $8.95]
FDA publishes a draft International Council for Harmonization M15 guidance on model-informed drug development principles.